Top

Published in:

01-09-2017 | Original Article

Cystitis due to capillaria infection in a dog and its treatment

Authors: S. Sivajothi, B. Sudhakara Reddy

Published in: Journal of Parasitic Diseases | Issue 3/2017

Abstract

Capillaria spp infection was diagnosed in a 3 year old dog with history of pollakiuria, dysuria and haematuria. Confirmatory diagnosis was done by demonstration of the parasitic ova in the urinary sediment, cystitis by ultrasonography, presence of proteins and leukocytes in the urine. Dog was successfully treated with fenbendazole and ivermectin along with supportive therapy. Recovery was noticed after 2 weeks of treatment with clear and transparent urine and absence of parasitic ova in urinary sediment.

Basso W, Spänhauer Z, Arnold S, Deplazes P (2014) Capillaria plica (syn. Pearsonema plica) infection in a dog with chronic pollakiuria: challenges in the diagnosis and treatment. Parasitol Int 63(1):140–142. doi:10.1016/j.parint.2013.09.002 CrossRefPubMed

Deplazes P, Eckert J, von Samson-Himmelstjerna G, Zahner H (2013) Lehrbuch der Parasitologie für die Tiermedizin, 3rd edn. Enke, Stuttgart

Inforzato GR, Santos WRM (2009) Capilariose em gatos. Revista Eletronica de Medicina Veterinaria 7(12):75–78

Reddy BS, Sivajothi S, Reddy LSSV, Raju KGS (2014a) Clinical and laboratory findings of Babesia infection in dogs. J Parasit Dis. doi:10.1007/s12639-014-0491-x PubMedCentral

Reddy BS, Kumari KN, Rao VV (2014b) Rayulu VC (2014b) Efficacy of cefpodoxime with clavulanic acid in the treatment of recurrent pyoderma in dogs. ISRN Vet Sci 467010:5. doi:10.1155/2014/467010

Sarma DK, Goswami S, Talukdar SK, Kalita D (2011) Urinary bladder worm in a dog and its successful treatment. Intas Polivet 12(I):107

Studzinska MB, Gałek JO, Kutrzepa MD, Tomczuk K (2015) Diagnosis and therapy of Capillaria plica infection: report and literature review. Acta Parasitol 60(3):563–566. doi:10.1515/ap-2015-0081 CrossRefPubMed

Title: Cystitis due to capillaria infection in a dog and its treatment
Authors: S. Sivajothi
B. Sudhakara Reddy
Publication date: 01-09-2017
Publisher: Springer India
Published in: Journal of Parasitic Diseases / Issue 3/2017
Print ISSN: 0971-7196
Electronic ISSN: 0975-0703
DOI: https://doi.org/10.1007/s12639-016-0855-5

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2017

Isolation and characterization of Toxoplasma gondii from small ruminants (sheep and goats) in Chennai City, South India

Comparative efficacy of deltamethrin and chlorpyriphos in bovine ticks in and around Jabalpur

Surgically managed human cystic echinococcosis in north-eastern Iran: a single center’s experience from 2001 to 2008

Ultrastructural studies of three species of Oesophagostomum (nematoda) by scanning electron microscopy

Distribution of larval and pupal stages of Simulium (Diptera: Simuliidae) flies in the Nilgiris hills of Tamil Nadu

Occurrence of Oesophagostomum species in slaughtered sheep in area of Hyderabad, Telangana State

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials